Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $34.3600 (2.48%) ($34.3600 - $34.3600) on Wed. May. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.5% (three month average) | RSI | 27 | Latest Price | $34.3600(2.48%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 1.1% a day on average for past five trading days. | Weekly Trend | TGTX declines -6.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(68%) ARKG(63%) IWO(59%) ARKK(58%) IBB(58%) | Factors Impacting TGTX price | TGTX will decline at least -1.75% in a week (0% probabilities). VIXM(-45%) VXX(-38%) UUP(-18%) UNG(-3%) TLT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.75% (StdDev 3.5%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $13.97(-59.34%) | Resistance Level | $36.88 | 5 Day Moving Average | $33.47(2.66%) | 10 Day Moving Average | $33.67(2.05%) | 20 Day Moving Average | $36.88(-6.83%) | To recent high | -31.8% | To recent low | 5.9% | Market Cap | $4.352b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |